Esomeprazole Magnesium
Product Images NDC 68071-2918

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Esomeprazole Magnesium (NDC 68071-2918). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Nucare Pharmaceuticals,inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Pdp (68071 2918 3)

Label for Esomeprazole Magnesium 40mg delayed-release capsules by NuCare Pharmaceuticals, Inc. The label shows a 30-count package and includes dosing instructions, manufacturer details, and NDC number 68071-2918-3. It also includes manufacturer and batch information from Dr. Reddy's Laboratories Limited, India, and retail warnings such as keeping out of reach of children and storage instructions.*

FDA Label Image

Figure1 (Figure1)

Chemical structure diagram of Esomeprazole Magnesium. The structure includes two identical organic moieties with a magnesium ion complexed and three water molecules indicated as part of the hydrate form.*

FDA Label Image

Figure2 (Figure2)

A line graph showing percent maintained over six months for esomeprazole magnesium at dosages of 40 mg, 20 mg, 10 mg, and a placebo. The 40 mg dosage maintains the highest percentage close to 100%, with lower dosages and placebo showing progressively lower maintenance percentages over time.*

FDA Label Image

Figure3 (Figure3)

A line chart comparing the percent maintained over 6 months for Esomeprazole Magnesium at 40 mg, 20 mg, 10 mg doses and placebo. The y-axis shows percent maintained, and the x-axis represents months. Different lines mark each dose and placebo with sample sizes indicated in the legend.*

FDA Label Image

Figure4 (Figure4)

A line graph showing the percent of patients symptom free over a period of diary days for three groups: Esomeprazole 40 mg, Esomeprazole 20 mg, and placebo. The x-axis represents the diary days from 0 to 28, and the y-axis indicates the percent of patients symptom free from 0 to 100%.*

FDA Label Image

Figure5 (Figure5)

Line graph showing the percent of patients symptom-free over 28 days for Esomeprazole 40 mg, Esomeprazole 20 mg, and placebo groups. The x-axis represents diary days from 0 to 28, and the y-axis shows the percent symptom-free from 0 to 100%. The graph compares symptom relief across the three treatment groups.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.